Home
About
Overview
Sharing Data
ORCID
Help
History (14)
Molecular dynamics - potential of mean force calculations as a tool for understanding ion permeation and selectivity in narrow channels.
Immunotherapy of metastatic breast cancer: phase I trail of reduced-intensity allogeneic hematopoietic stem cell transplantation with Th2/Tc2 T-cell exchange.
Nicotinic and opioid receptor interactions in nicotine addiction.
Perceived control and sleep in hospitalized older adults: a sound hypothesis?
EphB4 as a therapeutic target in mesothelioma.
See All 14 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
EphB4 as a therapeutic target in mesothelioma.
EphB4 as a therapeutic target in mesothelioma. BMC Cancer. 2013 May 30; 13:269.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Cell Line, Tumor
Drug Delivery Systems
Fluorescent Antibody Technique
Humans
Immunohistochemistry
In Situ Nick-End Labeling
Male
Mesothelioma
Mice
Mice, Inbred BALB C
Pleural Neoplasms
Receptor, EphB4
Serum Albumin
Xenograft Model Antitumor Assays
authors with profiles
Ravi Salgia